Measurement of Low‐Density Lipoprotein Cholesterol in Assessment and Management of Cardiovascular Disease Risk

Publisher： John Wiley & Sons Inc

E-ISSN： 1532-6535|96|1|20-22

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.96, Iss.1, 2014-07, pp. : 20-22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Association of total cholesterol, low‐density lipoprotein cholesterol, and non‐high‐density lipoprotein cholesterol with atherosclerotic cardiovascular disease and cancer in a Chinese male population

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 142, Iss. 6, 2018-03 ,pp. : 1209-1217

John Wiley & Sons Inc

Access to resources Recommend Favorite

Underutilization of Measurement of Serum Low‐Density Lipoprotein Cholesterol Levels and of Lipid‐Lowering Therapy in Older Patients with Manifest Atherosclerotic Disease

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 46, Iss. 9, 1998-09 ,pp. : 1128-1131

John Wiley & Sons Inc

Access to resources Recommend Favorite

Oxidized Low-Density Lipoprotein Cholesterol and Coronary Artery Disease

By  

Cardiology, Vol. 119, Iss. 2, 2011-09 ,pp. : 106-107

Karger

Access to resources Recommend Favorite

Perspectives on low-density lipoprotein cholesterol goal achievement

By Catapano Alberico L.  

Current Medical Research and Opinion, Vol. 25, Iss. 2, 2009-02 ,pp. : 431-447

Informa Healthcare

Access to resources Recommend Favorite

Future approaches to reducing low-density lipoprotein cholesterol

By Wierzbicki Anthony S  

Future Lipidology, Vol. 1, Iss. 4, 2006-08 ,pp. : 463-476

Future Medicine

Access to resources Recommend Favorite